Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

Lupin Ltd has introduced Ipratropium Bromide nasal spray in the US, available in 0.03% and 0.06% strengths. These sprays, ...

Lupin introduces ipratropium bromide nasal solution, 0.03% & 0.06% in US markets: Our Bureau, Mumbai Friday, July 4, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin ...

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

MomMed, a trusted maternal and family wellness brand, today announced a strategic partnership with nasal care innovator ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

Getting a cold once or twice a few months is normal, but what about a persistently blocked nose that lingers for weeks and ...

The FTC sued Xlear after it marketed its spray as a covid preventative. The Trump administration dropped the suit, but the ...

Ipratropium bromide nasal solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with ...

Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.